Alzheimer's Disease News and Research RSS Feed - Alzheimer's Disease News and Research Twitter

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
NPI leaders to invest more than $30M to support White House BRAIN Initiative

NPI leaders to invest more than $30M to support White House BRAIN Initiative

Leaders of the National Photonics Initiative (NPI), an alliance of top scientific societies uniting industry and academia to raise awareness of photonics, launched its Photonics Industry Neuroscience Group alongside officials from the White House Office of Science and Technology (OSTP) in conjunction with today's White House BRAIN Initiative conference. [More]
Protein that plays key role in neurological diseases regulates neuronal communication by self-association

Protein that plays key role in neurological diseases regulates neuronal communication by self-association

The protein alpha-synuclein is a well-known player in Parkinson's disease and other related neurological conditions, such as dementia with Lewy bodies. Its normal functions, however, have long remained unknown. [More]
AAN releases new position statement on opioids for chronic non-cancer pain

AAN releases new position statement on opioids for chronic non-cancer pain

According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain. [More]
Novel project to develop new models of care for depression in older adults

Novel project to develop new models of care for depression in older adults

UC Davis and the University of Washington are implementing a project to develop innovative new models of care for depression in older adults through a $2.5 million grant from the California-based Archstone Foundation, a private grant-making organization whose mission is to contribute toward the preparation of society in meeting the needs of an aging population. [More]
Research points to remote monitoring as offering way to improve patient care

Research points to remote monitoring as offering way to improve patient care

An aging population and an increased incidence of debilitating illnesses such as Parkinson's and Alzheimer's disease means there is pressure on technology to offer assistance with healthcare - monitoring and treatment. Research published in the International Journal of Ad Hoc and Ubiquitous Computing points to remote monitoring as offering a way to improve patient care and even accelerate medical research. [More]
UCLA research may lead to novel treatment for PH1

UCLA research may lead to novel treatment for PH1

Research by UCLA biochemists may lead to a new treatment - or even a cure - for PH1, a rare and potentially deadly genetic kidney disease that afflicts children. Their findings also may provide important insights into treatments for Parkinson's disease, Alzheimer's disease and other degenerative diseases. [More]
GSA and NAM select reporters for Journalists in Aging Fellows Program

GSA and NAM select reporters for Journalists in Aging Fellows Program

The Gerontological Society of America (GSA) and New America Media (NAM) have selected 19 reporters for the Journalists in Aging Fellows Program, now in its fifth year. [More]
NeuroEM begins study to test Transcranial Electromagnetic Treatment in aged primates

NeuroEM begins study to test Transcranial Electromagnetic Treatment in aged primates

NeuroEM Therapeutics, Inc., a Phoenix-based medical device R&D company, announced today that it has begun a study with a premiere research university to test its Transcranial Electromagnetic Treatment (TEMT) in aged primates. [More]
Self-reported memory complaints are strong predictors of Alzheimer's later in life

Self-reported memory complaints are strong predictors of Alzheimer's later in life

New research by scientists at the University of Kentucky's Sanders-Brown Center on Aging suggests that people who notice their memory is slipping may be on to something. [More]
UI study offers good news for care givers, health care providers

UI study offers good news for care givers, health care providers

A new University of Iowa study further supports an inescapable message: caregivers have a profound influence-good or bad-on the emotional state of individuals with Alzheimer's disease. [More]
People with memory loss more likely to develop dementia later, study finds

People with memory loss more likely to develop dementia later, study finds

New research suggests that people without dementia who begin reporting memory issues may be more likely to develop dementia later, even if they have no clinical signs of the disease. [More]
ACT for NIH seeks significant funding increase to enhance life-saving medical research

ACT for NIH seeks significant funding increase to enhance life-saving medical research

ACT for NIH: Advancing Cures Today announced a national, non-partisan effort to seek an immediate, significant funding increase for the National Institutes of Health (NIH) to enhance life-saving medical research for patients around the world. [More]
Leicester scientists lend a helping hand in fight against Alzheimer's and cancer

Leicester scientists lend a helping hand in fight against Alzheimer's and cancer

Chemists at the University of Leicester have reported a breakthrough in techniques to develop new drugs in the fight against diseases such as cancer and Alzheimer's. [More]
Experts to study how improved support for dementia carers can enhance quality of life

Experts to study how improved support for dementia carers can enhance quality of life

Experts will explore how improved support and powers for people caring for loved-ones with dementia can improve quality of life for both patients and carers around the UK. [More]
Simple test based on movement and thought can help identify Alzheimer's risk before signs of dementia

Simple test based on movement and thought can help identify Alzheimer's risk before signs of dementia

York University researchers say a simple test that combines thinking and movement can help to detect heightened risk for developing Alzheimer's disease in a person, even before there are any telltale behavioural signs of dementia. [More]
TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

TauRx Therapeutics Ltd has achieved its target enrolment of 700 subjects with mild Alzheimer's disease into the second of its two Phase III clinical trials of LMTX, a tau aggregation inhibitor, for the treatment of Alzheimer's disease. [More]
Researchers discover key cell-signaling pathway that contributes to development of Alzheimer's disease

Researchers discover key cell-signaling pathway that contributes to development of Alzheimer's disease

Researchers at Jacksonville's campus of Mayo Clinic have discovered a defect in a key cell-signaling pathway they say contributes to both overproduction of toxic protein in the brains of Alzheimer's disease patients as well as loss of communication between neurons - both significant contributors to this type of dementia. [More]
Research findings provide more details about earliest stages of neurodegenerative disease

Research findings provide more details about earliest stages of neurodegenerative disease

The link between a protein typically associated with Alzheimer's disease and its impact on memory and cognition may not be as clear as once thought, according to a new study from the University of Wisconsin-Madison's Waisman Center. [More]
People who experience migraine in middle age may develop movement disorders later in life

People who experience migraine in middle age may develop movement disorders later in life

A new study suggests that people who experience migraine in middle age may be more likely to develop Parkinson's disease, or other movement disorders later in life. Those who have migraine with aura may be at double the risk of developing Parkinson's, according to the study published in the September 17, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Study suggests potential treatment for cardiovascular disease in people with apoE4 gene variant

Study suggests potential treatment for cardiovascular disease in people with apoE4 gene variant

Researchers at UT-Southwestern Medical Center have found that the most common variant of the circulating protein apolipoprotein E, called apoE3, helps repair the lining of blood vessels. Individuals with another variant, called apoE4, do not get the benefit of this repair, putting them at higher risk for cardiovascular disease. [More]